Swedish Orphan Biovitrum AB (publ) Environmental Analytics
Environmental and financial analysis dashboard for Swedish Orphan Biovitrum AB (publ). Industry: MANUFACTURING
Company Overview for Swedish Orphan Biovitrum AB (publ)
Highlights
Showing data for FY2023
Operational Environmental Cost
$0.37m
Operational Environmental Cost Intensity
0.02%
Total Environmental Cost
$30m
Total Environmental Cost Intensity
1.36%
ΔOperational Environmental Cost (2020-2023)
$0.23m
Decoupling Rate (2020-2023)
-33%
Adjusted EBITDA
N/A
Adjusted EBITDA Margin
N/A
Environmental cost statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 26.81% | 21.61% | 21.56% | ||
| 0.01% | 0.01% | 0.01% | 0.01% | |
| 201.44% | 125.99% | 21.81% | ||
| 0.00% | 0.00% | 0.01% | 0.01% | |
| $0m | $0m | $0m | $0m | |
| 51.15% | 50.62% | 21.66% | ||
| 0.01% | 0.01% | 0.02% | 0.02% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| 98.35% | 2685.02% | 16.71% | ||
| 0.02% | 0.05% | 1.40% | 1.34% | |
| 87.74% | 2208.22% | 16.76% | ||
| 0.03% | 0.06% | 1.41% | 1.36% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2023
Integrated financial analysis
Highlights
Showing data for FY2023
Adjusted EBITDA Margin
N/A
Adjusted EBIT Margin
N/A
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$1,858m | $1,715m | $1,803m | $2,195m | |
| -7.70% | 5.14% | 21.73% | ||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $0m | $0m | $0m | |
| 0.01% | 0.01% | 0.02% | 0.02% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2023
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.01%
Scope 2 (% of Sales)
0.01%
Operational Environmental Cost Intensity
0.02%
Scope 3 (% of Sales)
1.34%
Total Environmental Cost Intensity
1.36%
Selected peer group
Showing data for FY2023
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Swedish Orphan Biovitrum AB (publ) | SE | $0m | 0.02% |
Loading similar companies data...
Industry distribution
Showing data for FY2023
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2023
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $50m | 52.83% | N/A | N/A |
Energy-related activities (3) | $0m | 0.25% | N/A | N/A |
Upstream transportation (4) | $10m | 10.11% | N/A | N/A |
Waste (5) | $1m | 1.44% | N/A | N/A |
Business travel (6) | $1m | 0.89% | N/A | N/A |
Commuting (7) | $0m | 0.08% | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $9m | 9.71% | N/A | N/A |
Processing of products (10) | $0m | 0.03% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $23m | 24.65% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $95m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2023